Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Zhuhai United Laboratories clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Zhuhai United Laboratories as lead sponsor. Synced 16 Oct 2026
3Current trials
1Recruiting now
0Drugs in these trials
1Trial register
At a glance

Zhuhai United Laboratories is the lead sponsor of 3 current clinical trials in our China register. 1 is recruiting patients now. The most common phase is Phase 1. The most-studied condition is Pharmacokinetics and Pharmacodynamics.

ClinicalTrials.gov trials by status

  • Recruiting133%
  • Not yet open267%

Trials by phase

  • Phase 1267%
  • Not applicable133%
01

Clinical trials sponsored by Zhuhai United Laboratories

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
To Evaluate Safety, Tolerability, PK/PD & Food Effect of Single/Multiple Oral TUL321 Capsules in Healthy Participants.
NCT07760467 · ClinicalTrials.gov ↗ · Paroxysmal Nocturnal Hemoglobinuria, PNH
Phase 1 Recruiting 2026-08 China
Comparison of the Pharmacokinetic (PK) and Pharmacodynamic (PD) Biosimilarity of Insulin Aspart 30 Injections After Single-Dose Subcutaneous Administration to Healthy Volunteers
NCT07875803 · ClinicalTrials.gov ↗ · Pharmacokinetics and Pharmacodynamics
Not applicable Not yet open 2026-10 China
Evaluation of the Safety, Tolerability and Pharmacokinetics of TUL108 for Injection in Healthy Participants (SAD/ MAD)
NCT07719257 · ClinicalTrials.gov ↗ · Complicated Urinary Tract Infections(cUTI)
Phase 1 Not yet open 2026-07 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Zhuhai United Laboratories trials

3 conditions
Pharmacokinetics and Pharmacodynamics1Complicated Urinary Tract Infections(cUTI)1Paroxysmal Nocturnal Hemoglobinuria, PNH1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in China31

A trial with sites in more than one country appears in each of those registers.

04

Questions about Zhuhai United Laboratories trials

How many clinical trials does Zhuhai United Laboratories sponsor?

Zhuhai United Laboratories is the lead sponsor of 3 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 16 October 2026. Completed and withdrawn studies are not counted.

Are Zhuhai United Laboratories trials recruiting?

Yes. 1 of its 3 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 16 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.